The Role of Artificial Intelligence in the Development of Smart and Targeted Drug Nanocarriers

سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 47

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

AIMS02_568

تاریخ نمایه سازی: 29 تیر 1404

چکیده مقاله:

Background and Aims: Background and Objectives: In recent years, artificial intelligence and nanotechnology have dramatically changed the path of drug design and targeted therapies. The combination of these two technologies has helped develop nanocarriers that deliver drugs precisely to the desired site in the body, thereby both increasing the effectiveness of treatment and reducing side effects. This study examines the role of artificial intelligence in the development of smart drug nanocarriers. Methods: This review was conducted systematically. A search was conducted in the reputable databases PubMed, Scopus, and Google Scholar in the period ۲۰۲۰-۲۰۲۵ with the keywords Artificial Intelligence, Nano drug carriers, Smart drug delivery, Targeted drug delivery, Machine learning in drug design, and Nanotechnology in pharmaceutical sciences. Finally, ۳۰ relevant articles that met the defined inclusion criteria (articles published in English, full-text access, and focused on AI applications in drug nanocarriers) were selected for content analysis. Results: The review findings specify that most of the AI algorithms particularly machine learning models such as Random Forest, SVM, and Convolutional Neural Networks (CNN) have a vital role in the drug nanocarrier design specifications. These studies assessed biological and chemical data to give a more accurate prediction of toxicity, pharmacokinetics, and therapeutic efficacy of nanoparticles. Artificial intelligence also facilitates the design of nanostructures more responsive to pH, enzyme activity, and cellular receptors through molecular dynamics simulations and optimization of targeted drug release. It is true that AI technologies have increased the speed of design, but they also improve the likelihood of clinical success and effectiveness of nanoformulations. Conclusion: The application of artificial intelligence to design smart, targeted drug nanocarriers can even go further and

کلیدواژه ها:

Artificial Intelligence ، Nano drug carriers ، Smart drug delivery ، Targeted drug delivery ، Machine learning in drug design ، Nanotechnology in pharmaceutical sciences

نویسندگان

Mohammad Bastani

Bachelor of Health Information Technology, Department of Health Information Technology, School of Paramedical Sciences, Aja University of Medical Sciences, Tehran, Iran

Mohammad Alizadeh

Bachelor of Laboratory Sciences, Department of Laboratory Sciences, School of Paramedical Sciences, Aja University of Medical Sciences, Tehran, Iran

Nahid Mehrabi

Assistant Professor, Department of Health Information Technology, School of Paramedical Sciences, Aja University of Medical Sciences, Tehran, Iran

Aynaz Esmailzadeh

Bachelor of Health Information Technology, Department of Health Information Technology, Varastegan Institute for Medical Sciences, Mashhad, Iran

Mahdi Ghorbani

Assistant Professor, Department of Laboratory Sciences, School of Paramedical Sciences, Aja University of Medical Sciences, Tehran, Iran